Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 CHA Q4 2025 Earnings EPS Misses Estimates by Wide Margin GTY Q1 2026 Earnings Strong EPS Surprise Drives Modest Stock Uptick GOODN Q1 2026 Earnings Preferred Stock Reports Strong EPS Surprise NPCE Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Surprise Baytex Energy Q1 2026 Earnings Significant Miss as EPS Turns Negative